MySTYL'One
July 26, 2022
Replay of the webinar
--> MySTYL'One members: access the webinar page for the full replay
--> Not a member, but would like to view the video? Fill out online request form: https://form.jotform.com/222024289539055
Access the replay of the webinar "Fundamental Investigations on Bilayer tablets - Effects of Process Parameters and Geometry on Interfacial Strength" with thanks to the links above.
Speakers:
*Jan Finke, Division Head Pharma & Bioparticle Technology, iPAT, TU Braunschweig &am...
Replay of the webinar
--> MySTYL'One members: access the webinar page for the full replay
--> Not a member, but would like to view the video? Fill out online request form: https://form.jotform.com/222024289539055
Access the replay of the webinar "Fundamental Investigations on Bilayer tablets - Effects of Process Parameters and Geometry on Interfacial Strength" with thanks to the links above.
Speakers:
*Jan Finke, Division Head Pharma & Bioparticle Technology, iPAT, TU Braunschweig & Senior Scientist, Fraunhofer IST
*Bruno Leclercq, Science Lab Head and Business Development Manager, MEDELPHARM
Webinar agenda:
Why should you watch?
pharmaceutical-technology
July 25, 2022
On this article you will find how pharmaceutical companies can improve the efficiency of their entire product development and drug commercialisation process with the ever-rising costs of bringing a drug to market. A well-known source of bottlenecks, delays, and technical setbacks is process scale-up, where production moves from the laboratory to full-scale GMP manufacturing
pharmaceutical-technology
July 20, 2022
Tablets are by far the most widely used pharmaceutical dosage form, followed by capsules. Tablets are cost-effective, stable, and easy-to-administer. The main advantage is that compression allows for high speed manufacturing with a very high level of quality control. As such, tablets have been popular among pharmacists since the emergence of the tablet compression industry in the mid-20th century. Despite this long history, the industry is continually improving this dosage form to advance pat...
Tablets are by far the most widely used pharmaceutical dosage form, followed by capsules. Tablets are cost-effective, stable, and easy-to-administer. The main advantage is that compression allows for high speed manufacturing with a very high level of quality control. As such, tablets have been popular among pharmacists since the emergence of the tablet compression industry in the mid-20th century. Despite this long history, the industry is continually improving this dosage form to advance patient care. Meanwhile, the processes and equipment it uses to manufacture these products are also advancing.
MySTYL'One
June 15, 2022
- The event is now over - Stay tuned for additional info soon
June 28th, 3 pm (Paris Time)
"Fundamental investigations on bilayer tablets - Effects of process parameters and geometry on interfacial strength"
#multilayer #tablet #interfacial adhesion #delamination #tablet geometry
MySTYL'One
Dec. 1, 2021
Article published on Pharmaceutical Online that reviews selecting this specific dosage form, manufacturing challenges and how to
overcome them, considerations for evaluating a CDMO, and the typical timeframe
for scale-up.
Access the news HERE.
www.korsch.com
Sept. 6, 2021
“The manufacturing of multilayer tablets may seem to be simple duplications of the basic single-layer compression cycle, but in reality, the process is far more complicated. In this article, KORSCH outlines the key considerations in the production of multilayer tablets and defines the key parameters for multilayer process optimization.” Click here for full article
Skyepharma
March 15, 2021
MySTYL'One users exclusive!
Flashback on Aline Moulin (Skyepharma)'s presentation at CSF Cambridge 2018.
Discover the presentation of Skyepharma's study: "Correlation between STYL’One Evolution and an industrial rotary press on a tab-in-tab dosage form" directly in our library of bulletins (access is only open to STYL'One users)
#multilayer #controlled release #industrial rotary press #compaction simulator #tab-in-tab